Divi's Laboratories Limited (DIVISLAB) Cash Flow Statement

A cash flow statement shows the actual cash a company generated and spent across operating, investing, and financing activities over a reporting period.

Divi's Laboratories Limited engages in the manufacture and sale of generic active pharmaceutical ingredients (APIs), intermediates, and nutraceuticals in India, North America, Asia, Europe, and internationally.

Total Cash From Operating Activities Chart for Divi's Laboratories Limited

Divi's Laboratories Limited (DIVISLAB) operating cash flow for FY2026 was INR 30.2B, a 55.0% change from FY2025. Divi's Laboratories Limited's operating cash flow grew from INR 347.7M in 2005 to INR 30.2B in 2026 (8577.0% over 21 years). Operating cash flow compound annual growth rate: 5-year CAGR of 9.2%, 10-year CAGR of 11.3%, 20-year CAGR of 22.9%.

The most recent 3 years are real; the rest is blurred as a preview. Sign up free to unlock every line item, quarterly data, and the real full history. Free account: 8 years of history for 10 flagship companies. Premium: full history for 500+ companies. Premium is €10.00/month. See pricing.